Efficacy of adalimumab in Behçet's disease. Description of 6 cases

Statistics

Eficacia del adalimumab en la enfermedad de Behçet: descripción de 6 casos

Javier Calvo Cataláa,

, Cristina Campos Fernandeza, Amalia Rueda Cida, Maria Isabel Gonzalez-Cruz Cervelleraa, Aurelio Baixauli Rubiob, Maria Dolores Pastor Cubilloa

a Servicio de Reumatología y Metabolismo Óseo, Consorcio Hospital General Universitario, Valencia, Spain

b Servicio de Medicina Interna, Hospital de Manises, Valencia, Spain

Read

7447

Times
was read the article

4279

Total PDF

3168

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/S2173-5743(11)70056-9

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 10	4	184	188
2025 9	0	175	175
2025 8	0	142	142
2025 7	0	222	222
2025 6	2	112	114
2025 5	91	92	183
2025 4	62	72	134
2025 3	89	55	144
2025 2	63	63	126
2025 1	52	54	106
2024 12	42	57	99
2024 11	47	72	119
2024 10	36	52	88
2024 9	38	32	70
2024 8	51	46	97
2024 7	21	50	71
2024 6	25	33	58
2024 5	27	40	67
2024 4	16	24	40
2024 3	22	40	62
2024 2	22	28	50
2024 1	15	22	37
2023 12	21	37	58
2023 11	18	26	44
2023 10	31	31	62
2023 9	21	43	64
2023 8	14	16	30
2023 7	19	23	42
2023 6	10	23	33
2023 5	11	11	22
2023 4	9	9	18
2023 3	20	28	48
2023 2	20	25	45
2023 1	11	24	35
2022 12	28	30	58
2022 11	24	32	56
2022 10	26	31	57
2022 9	19	35	54
2022 8	23	50	73
2022 7	21	46	67
2022 6	18	50	68
2022 5	21	45	66
2022 4	29	53	82
2022 3	22	63	85
2022 2	19	44	63
2022 1	20	38	58
2021 12	19	38	57
2021 11	18	61	79
2021 10	39	71	110
2021 9	29	52	81
2021 8	27	62	89
2021 7	17	54	71
2021 6	28	45	73
2021 5	21	50	71
2021 4	79	123	202
2021 3	28	33	61
2021 2	37	32	69
2021 1	28	31	59
2020 12	25	30	55
2020 11	29	23	52
2020 10	15	15	30
2020 9	20	22	42
2020 8	19	26	45
2020 7	21	20	41
2020 6	25	23	48
2020 5	25	23	48
2020 4	10	16	26
2020 3	13	7	20
2020 2	2	0	2
2020 1	10	0	10
2019 9	4	0	4
2019 6	2	0	2
2019 3	2	0	2
2019 1	1	0	1
2018 5	2	3	5
2018 4	22	9	31
2018 3	29	17	46
2018 2	13	2	15
2018 1	8	3	11
2017 12	14	5	19
2017 11	15	4	19
2017 10	16	9	25
2017 9	15	10	25
2017 8	10	6	16
2017 7	5	6	11
2017 6	22	7	29
2017 5	25	7	32
2017 4	12	20	32
2017 3	14	33	47
2017 2	12	5	17
2017 1	19	8	27
2016 12	45	7	52
2016 11	24	5	29
2016 10	38	4	42
2016 9	28	3	31
2016 8	20	6	26
2016 7	15	7	22
2016 6	0	6	6
2016 5	1	14	15
2016 4	1	10	11
2016 3	0	8	8
2016 2	1	8	9
2016 1	2	0	2
2015 12	6	0	6
2015 10	0	12	12
2015 9	1	0	1
2015 7	7	5	12
2015 6	23	21	44
2015 5	36	22	58
2015 4	23	36	59
2015 3	33	21	54
2015 2	27	14	41
2015 1	55	15	70
2014 12	34	33	67
2014 11	13	21	34
2014 10	19	27	46
2014 9	21	14	35
2014 8	16	25	41
2014 7	15	19	34
2014 6	50	18	68
2014 5	36	18	54
2014 4	24	21	45
2014 3	35	19	54
2014 2	26	11	37
2014 1	23	18	41
2013 12	29	16	45
2013 11	20	13	33
2013 10	28	15	43
2013 9	27	20	47
2013 8	35	15	50
2013 7	27	43	70
2013 6	23	21	44
2013 5	31	24	55
2013 4	35	25	60
2013 3	29	19	48
2013 2	23	22	45
2013 1	19	20	39
2012 12	18	22	40
2012 11	16	20	36
2012 10	11	21	32
2012 9	12	4	16
2012 7	1	0	1
2012 6	1	0	1
2012 5	1	0	1
2012 4	4	0	4
2012 3	5	0	5
2012 2	2	0	2
2012 1	4	0	4
2011 12	5	0	5
2011 11	8	0	8
2011 10	3	0	3
2011 9	2	0	2
2011 8	1	0	1
2011 7	4	0	4

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter